Ann: Appendix 3B, page-7

Spoke to Investor Relations this afternoon about the SP whether BOD is doing anything to support in meantime. Their response:

"The board is focused on preparations for the release of the clinical trial results (whenever that may be) and marketing and PR around these as appropriate. Part of this will include investor marketing activities also. In the meantime, the company is concentrating on other operational progress it can make such as the improvements to the device and distribution partner activities."